Physician

Wissam Gharib, M. D.

According to 2025 Medicare claims, Wissam Gharib, M. D. (NPI: 1386757037) practices interventional cardiology in the Morgantown, WV market, with the plurality of this provider's patient population coming from Monongalia, WV. This provider's primary affiliated billing organization is MONONGALIA COUNTY GENERAL HOSPITAL COMPANY (NPI: 1447673223; TIN: 237441353) and primary practice location at 26505-3494. Gharib is affiliated with the ACO West Virginia (ACO ID: A3563), Vandalia Health Network (ACO ID: A4513), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Gharib's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,237 traditional Medicare patients, billed 3,248 HCPCS/CPT codes, and received $211,576 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,660 prescription claims across 347 beneficiaries totaling $270,268 in drug costs, led by Entresto (Sacubitril/Valsartan). 2016 DME data shows 11 claims. Open Payments data shows 207 records totaling $80,035. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $128,248 to $270,268. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	675	1,508	$197,782
2016	1,014	1,949	$181,617
2017	N/R	N/R	N/R
2018	609	1,657	$176,214
2019	789	2,097	$202,364
2020	685	1,685	$152,530
2021	787	1,799	$180,602
2022	632	1,555	$200,679
2023	759	2,330	$180,749
2024	1,237	3,248	$211,576

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	174	1,340	$128,248
2016	201	1,739	$155,086
2017	117	587	$55,818
2018	147	623	$55,599
2019	204	1,046	$143,582
2020	249	1,266	$170,852
2021	292	1,233	$151,279
2022	302	1,492	$178,741
2023	331	1,513	$255,883
2024	347	1,660	$270,268

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$24,106
2016	N/R	11	$22,372
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	258	315	$65
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	279	284	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	182	207	$11
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	231	264	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	666	827	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	57	4,218	$90,724
Repatha Sureclick	Evolocumab	44	2,184	$42,172
Eliquis	Apixaban	42	1,680	$31,093
Xarelto	Rivaroxaban	24	1,680	$29,923
Brilinta	Ticagrelor	38	1,800	$25,724

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	176	$14,371	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	31	$65,664	Recor Medical Inc
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Wissam Gharib, M. D.?

Tedicare shows public-source Medicare data for Wissam Gharib, M. D. (NPI 1386757037), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wissam Gharib, M. D. have ACO affiliation data?

Wissam Gharib, M. D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563), Vandalia Health Network (MSSP, ACO ID A4513), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Wissam Gharib, M. D.?

Wissam Gharib, M. D. is linked to MONONGALIA COUNTY GENERAL HOSPITAL COMPANY (billing NPI 1447673223) in the available physician profile data.

Does Wissam Gharib, M. D. have Open Payments data?

Wissam Gharib, M. D. has 207 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.